SCHNEIDERMAN DANIEL H (Interim Chief Accting Officer) received a stock award from PASITHEA THERAPEUTICS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/1/2025ACC: 0001213900-25-116306
Officer· Interim Chief Accting Officer
Since Aug 2022
+26.67K
Net shares
Net buyer
$20.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
26.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+26.67K
Price / share
$0.75
Trade value
$20K
% of position
New position
11/28/2025
0.00→26.67K
Total
Net shares
+26.67K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2025 | A · Award | +26.67K | $0.75 | $20K | New position | 0.00 | 26.67K |
| Total | +26.67K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported